MORE VIDEOS
Udforsk mere
Brystkræft

Næste

Automatisk afspilning
What is hobnail??? Vascular tumor basics (pathology dermpath dermatology dermatopathology)
00:01:39
What is hobnail??? Vascular tumor basics (pathology dermpath dermatology dermatopathology)
3 Visninger . 12/07/23 administrator
Vascular Tumors of Skin (31 cases in 3 hours): Board Review for Pathology Dermatology Dermpath
02:46:44
Vascular Tumors of Skin (31 cases in 3 hours): Board Review for Pathology Dermatology Dermpath
7 Visninger . 12/07/23 administrator
Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]
00:01:46
Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]
6 Visninger . 11/26/23 administrator
Sebaceous Carcinoma: Dermpath in 5 Minutes - pathology dermatology dermatopathology skin cancer
00:03:16
Sebaceous Carcinoma: Dermpath in 5 Minutes - pathology dermatology dermatopathology skin cancer
8 Visninger . 11/26/23 administrator
Basal Cell Carcinoma (BCC) of Eyelid - For Ophthalmology Residents
00:04:29
Basal Cell Carcinoma (BCC) of Eyelid - For Ophthalmology Residents
2 Visninger . 11/26/23 administrator
Amyloidosis for medical students & dermatology residents I Dr.Ram sushruth
00:26:14
Amyloidosis for medical students & dermatology residents I Dr.Ram sushruth
5 Visninger . 11/23/23 administrator
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
00:03:06
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
3 Visninger . 08/09/23 administrator
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
00:02:51
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
3 Visninger . 08/09/23 administrator
The Importance of Collaboration in Treating CTCL (Chapter 7)
00:02:30
The Importance of Collaboration in Treating CTCL (Chapter 7)
3 Visninger . 08/09/23 administrator
The CTCL diagnosis journey
00:00:20
The CTCL diagnosis journey
7 Visninger . 08/09/23 administrator
Unmet needs for late-stage CTCL
00:01:10
Unmet needs for late-stage CTCL
3 Visninger . 08/09/23 administrator
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
00:01:16
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Visninger . 08/09/23 administrator
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
00:01:35
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
4 Visninger . 08/09/23 administrator
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
00:08:49
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
12 Visninger . 08/09/23 administrator
Pre-clinical activity of tipifarnib in CTCL
00:02:12
Pre-clinical activity of tipifarnib in CTCL
6 Visninger . 08/09/23 administrator
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
00:04:47
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
4 Visninger . 08/09/23 administrator
CTCL 06 2017
02:28:08
CTCL 06 2017
2 Visninger . 08/09/23 administrator
Brentuximab vedotin for CTCL
00:02:30
Brentuximab vedotin for CTCL
2 Visninger . 08/09/23 administrator
Clonal evolution in patients with CTCL
00:02:24
Clonal evolution in patients with CTCL
4 Visninger . 08/09/23 administrator

Etiopathogenesis of CTCL for dermatology residents I Dr.P.Ram Sushruth

2 Visninger • 08/09/23
Del
Indlejre
administrator
administrator
Abonnenter
0

this is a brief educational video for dermatology residents and medical students that etiopathogenesis of cutaneous T cell lymphomas.
For any queries mail to: sushruth93@gmail.com

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning

What is hobnail??? Vascular tumor basics (pathology dermpath dermatology dermatopathology)
00:01:39
What is hobnail??? Vascular tumor basics (pathology dermpath dermatology dermatopathology)
3 Visninger . 12/07/23 administrator
Vascular Tumors of Skin (31 cases in 3 hours): Board Review for Pathology Dermatology Dermpath
02:46:44
Vascular Tumors of Skin (31 cases in 3 hours): Board Review for Pathology Dermatology Dermpath
7 Visninger . 12/07/23 administrator
Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]
00:01:46
Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]
6 Visninger . 11/26/23 administrator
Sebaceous Carcinoma: Dermpath in 5 Minutes - pathology dermatology dermatopathology skin cancer
00:03:16
Sebaceous Carcinoma: Dermpath in 5 Minutes - pathology dermatology dermatopathology skin cancer
8 Visninger . 11/26/23 administrator
Basal Cell Carcinoma (BCC) of Eyelid - For Ophthalmology Residents
00:04:29
Basal Cell Carcinoma (BCC) of Eyelid - For Ophthalmology Residents
2 Visninger . 11/26/23 administrator
Amyloidosis for medical students & dermatology residents I Dr.Ram sushruth
00:26:14
Amyloidosis for medical students & dermatology residents I Dr.Ram sushruth
5 Visninger . 11/23/23 administrator
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
00:03:06
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
3 Visninger . 08/09/23 administrator
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
00:02:51
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
3 Visninger . 08/09/23 administrator
The Importance of Collaboration in Treating CTCL (Chapter 7)
00:02:30
The Importance of Collaboration in Treating CTCL (Chapter 7)
3 Visninger . 08/09/23 administrator
The CTCL diagnosis journey
00:00:20
The CTCL diagnosis journey
7 Visninger . 08/09/23 administrator
Unmet needs for late-stage CTCL
00:01:10
Unmet needs for late-stage CTCL
3 Visninger . 08/09/23 administrator
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
00:01:16
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Visninger . 08/09/23 administrator
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
00:01:35
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
4 Visninger . 08/09/23 administrator
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
00:08:49
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
12 Visninger . 08/09/23 administrator
Pre-clinical activity of tipifarnib in CTCL
00:02:12
Pre-clinical activity of tipifarnib in CTCL
6 Visninger . 08/09/23 administrator
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
00:04:47
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
4 Visninger . 08/09/23 administrator
CTCL 06 2017
02:28:08
CTCL 06 2017
2 Visninger . 08/09/23 administrator
Brentuximab vedotin for CTCL
00:02:30
Brentuximab vedotin for CTCL
2 Visninger . 08/09/23 administrator
Clonal evolution in patients with CTCL
00:02:24
Clonal evolution in patients with CTCL
4 Visninger . 08/09/23 administrator